Newstin - Peregrine Pharmaceuticals

Peregrine Pharmaceuticals - News

Thu, 26 Nov 2009 23:01:24 GMT

You are currently using FREE feeds from Newstin. You will get more data and services with Newstin Pro RSS licensed subscription.
Newstin Pro RSS provides aggregated and categorized news content covering 1.25 Million news categories from 160.000 online sources in the format that can be easily integrated into environment or software of your choice. Read more about Newstin Pro RSS or download the product presentation now.

Peregrine Pharmaceuticals, Inc. (PPHM) Results From Two Phase II Trials Add to Understanding of...

Thu, 19 Nov 2009 15:40:00 GMT

Peregrine Pharmaceuticals Presents Promising Antiviral Data at 2009 Chemical and Biological...

Wed, 18 Nov 2009 14:35:30 GMT

70 Companies Confirmed to Present at OneMedForum 2010 Investment Conference

Tue, 17 Nov 2009 19:47:48 GMT

FDA's BPAC renders positive opinion on Phase III clinical trial of INTERCEPT Blood System

Tue, 17 Nov 2009 08:14:30 GMT

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Wed, 11 Nov 2009 06:51:09 GMT

Peregrine Pharmaceuticals Awarded Second Broad U.S. Patent for Anti-Viral Applications of...

Wed, 04 Nov 2009 19:43:53 GMT

Enrollment for Phase 2 clinical study of NKTR-102 completed ahead of schedule

Wed, 28 Oct 2009 12:10:28 GMT

Peregrine Pharmaceuticals Inc-Therapeutic Competitors - research report released

Wed, 28 Oct 2009 09:57:01 GMT

50 Companies Already Confirmed to Present at 'The OneMedForum 2010 Finance Conference'

Mon, 26 Oct 2009 15:35:00 GMT